Trial Profile
Vagal Mechanisms Mediating the Effects of Glucagon-Like Peptide 1 (GLP-1) on the Endocrine Pancreas - the Entero-endocrine Axis.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 May 2018 Planned End Date changed from 1 Jul 2017 to 1 Oct 2018.
- 20 May 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2018.
- 25 Oct 2016 New trial record